News
Press Center
Boehringer Ingelheim has concluded phase one of their localization effort aimed at manufacturing their innovative thrombolytic medicines in Russia: the first batches of Metalyse (tenectaplase) for acute heart attack treatment were produced at NPO Petrovax Pharm facilities.
More
Topics Petrovax Pharm Researchers compared the 300 most affluent business people and upper-level managers in the largest companies in Russia, both state-owned and private. The ranking was compiled based on the number of mentions in Russia’s main media outlets between January 1 and December 31, 2016; additionally, researchers analyzed print material from 100 leading foreign newspapers and magazines. Both Forbes and the readers selected Vladimir Potanin as an Entrepreneur with a track record of achievement in large-scale projects that benefit society.
More
Topics Charity